Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study

Federico Montini; Agostino Nozzolillo; Paola M. V. Rancoita; Chiara Zanetta; Lucia Moiola; Federica Cugnata; Federica Esposito; Maria A. Rocca; Vittorio Martinelli; Massimo Filippi

doi:10.1007/s00415-023-11618-0

Related publications

Article2023

Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis: A Single-Centre Case-Control Study (P2-5.028)

Federico Montini, Agostino Nozzolillo, Paola M. V. Rancoita, Chiara Zanetta, Lucia Moiola, Federica Esposito, Federica Cugnata, Maria A. Rocca, Massimo Filippi, Vittorio Martinelli

Article2021

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

Zenas Z N Yiu, X orcid, G. Harding‐Oredugba, Christopher Em Griffiths, Richard B. Warren, Emma McMullen, H.J.A. Hunter

Letter2021

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

Zenas Z N Yiu, G. Harding‐Oredugba, Christopher Em Griffiths, Richard B. Warren, Emma McMullen, H.J.A. Hunter

Article2022

The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

Marta Ponzano, Irene Schiavetti, Roberto Bergamaschi, Enrico Pisoni, Andrea Bellavia, Giulia Mallucci, Luca Carmisciano, Matilde Inglese, Cinzia Cordioli, Girolama Alessandra Marfia, Eleonora Cocco, Paolo Immovilli, Ilaria Pesci, Cinzia Scandellari, Paola Cavalla, Marta Radaelli, Marika Vianello, Francesca Vitetta, Sara Montepietra, Maria Pia Amato, Cristina Fioretti, Massimo Filippi, ,

Preprint2020

COVID-19 in Teriflunomide-Treated Patients with Multiple Sclerosis

Amir‐Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana Beretich, James Stankiewicz, Shahamat Tauhid, Ann Cabot, Idanis Berriosmorales, Tamara HW Schwartz, Jacob A. Sloane, Mark S. Freedman, Massimo Filippi, Howard L. Weiner, Rohit Bakshi

Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study

Discussion(0)

Related publications

Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis: A Single-Centre Case-Control Study (P2-5.028)

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

COVID-19 in Teriflunomide-Treated Patients with Multiple Sclerosis